CN1772120A - 一种中药组合物 - Google Patents
一种中药组合物 Download PDFInfo
- Publication number
- CN1772120A CN1772120A CNA2005101182722A CN200510118272A CN1772120A CN 1772120 A CN1772120 A CN 1772120A CN A2005101182722 A CNA2005101182722 A CN A2005101182722A CN 200510118272 A CN200510118272 A CN 200510118272A CN 1772120 A CN1772120 A CN 1772120A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- fructus
- chinese
- granule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 95
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 229940079593 drug Drugs 0.000 title claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 17
- 201000010099 disease Diseases 0.000 claims abstract description 15
- 210000004369 blood Anatomy 0.000 claims abstract description 12
- 239000008280 blood Substances 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000005787 Cistanche Species 0.000 claims description 14
- 239000006187 pill Substances 0.000 claims description 14
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims description 13
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 13
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 13
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 claims description 12
- 229940096998 ursolic acid Drugs 0.000 claims description 12
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 238000003809 water extraction Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 29
- 241000700159 Rattus Species 0.000 description 25
- 241001465754 Metazoa Species 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 13
- 239000000047 product Substances 0.000 description 10
- 210000001550 testis Anatomy 0.000 description 9
- 230000037396 body weight Effects 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 208000031975 Yang Deficiency Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 239000011800 void material Substances 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000000918 epididymis Anatomy 0.000 description 4
- 201000010063 epididymitis Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 210000002149 gonad Anatomy 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 206010029446 nocturia Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 210000003194 forelimb Anatomy 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000001625 seminal vesicle Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000019100 sperm motility Effects 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 201000010653 vesiculitis Diseases 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010061819 Disease recurrence Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- -1 drying Substances 0.000 description 1
- 230000009986 erectile function Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940095686 granule product Drugs 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(g/kg) | 精子总数×104/ml | 活精子数×104/ml | 活精子百分率% | 死精子数×104/ml | 死精子百分率% |
对照男宝胶囊藿杞颗粒藿杞颗粒藿杞颗粒 | ----0.40.60.40.2 | 220.6±124.1226.1±108.9193.3±99.4193.0±111.8222.1±113.8 | 116.3±70.8143.4±89.6135.4±84.5109.5±60.9116.6±61.1 | 52.763.370.056.752.5 | 104.3±62.781.7±37.358.2±21.981.5±54.5105.6±55.5 | 47.336.730.043.347.5 |
组别 | 剂量(g/kg) | 睾丸(g/100g) | 包皮腺(mg/100g) | 精液囊+前列腺(mg/100g) | 胸腺(mg/100g) | 脾脏(mg/100g) |
对照组藿杞颗粒藿杞颗粒藿杞颗粒男宝胶囊 | -0.40.60.40.2 | 1.07±0.101.26±0.14*1.26±0.21*1.12±0.071.16±0.07* | 47.35±5.6747.67±2.4549.35±6.0347.39±8.3647.33±4.32 | 247.67±32.20275.56±19.33*267.34±27.35276.67±35.86260.26±34.31 | 230.25±22.78243.95±14.85257.23±16.86246.23±54.94244.96±20.26 | 483.34±45.15507.65±71.38560.93±63.09*475.15±69.11535.64±78.51 |
组别 | 剂量(g/kg) | 阴茎勃起潜伏期(S) |
正常对照去势模型丙酸睾丸素藿杞颗粒藿杞颗粒藿杞颗粒男宝胶囊 | 等体积水等体积水0.0020.600.400.200.40 | 16.26±6.2936.45±19.32**14.03±7.93**19.10±8.77*18.94±10.26*20.11±8.14*20.57±7.67* |
组别 | 剂量(g/kg) | 自主活动次数(10min) | 低温游泳存活时间(s) | 体重(g) | ||
给药前 | 给药后 | 差值 | ||||
对照阳虚模型苁蓉补肾藿杞颗粒藿杞颗粒藿杞颗粒 | 等体积水25mg0.400.600.400.20 | 2008±5311338±493**1785±363*1840±389**1706±429*1626±401* | 547±197.0394.3±166.22562.1±157.90*694.6±168.00***651.5±290.40*569.8±146.50* | 19.5±0.8519.5±0.8519.4±1.0719.4±1.0719.2±1.0319.5±0.85 | 25.02±1.8522.8±2.4523.22±1.8023.91±2.3823.18±1.3623.38±2.00 | 5.523.303.824.513.983.88 |
组别 | 剂量(g/kg) | 扑捉(20min内) | 射精(20min内) | ||||
潜伏期(s) | 次数 | % | 潜伏期(s) | 次数 | % | ||
正常对照组男宝胶囊藿杞颗粒藿杞颗粒藿杞颗粒 | 等体积水0.400.600.400.20 | 292.63±67.31195.63±68.86*171.40±65.20**194.67±70.34*191.78±53.93** | 9.13±4.2515.63±5.50*15.40±6.69*12.11±5.408.89±4.54 | 80801009090 | 903.75±142.68783.00±265.31505.43±237.18*654.00±201.17664.4±367.88 | 2.75±1.713.60±1.145.00±1.15*3.40±2.303.40±3.78 | 4060705050 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101182722A CN1329056C (zh) | 2005-10-22 | 2005-10-22 | 一种治疗肾阳不足、精血亏虚的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101182722A CN1329056C (zh) | 2005-10-22 | 2005-10-22 | 一种治疗肾阳不足、精血亏虚的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1772120A true CN1772120A (zh) | 2006-05-17 |
CN1329056C CN1329056C (zh) | 2007-08-01 |
Family
ID=36759371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101182722A Active CN1329056C (zh) | 2005-10-22 | 2005-10-22 | 一种治疗肾阳不足、精血亏虚的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1329056C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079500A (zh) * | 2015-09-21 | 2015-11-25 | 南京正亮医药科技有限公司 | 一种治疗阳痿的中药软膏 |
CN105853867A (zh) * | 2016-05-12 | 2016-08-17 | 广西百琪药业有限公司 | 一种治疗肾阳不足和气血两虚的药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1184659A (zh) * | 1997-11-14 | 1998-06-17 | 张锡昆 | 补肾健脾胃中药 |
CN1416835A (zh) * | 2001-11-08 | 2003-05-14 | 钟凯 | 一种系统治疗男性性功能障碍的中药药剂 |
-
2005
- 2005-10-22 CN CNB2005101182722A patent/CN1329056C/zh active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079500A (zh) * | 2015-09-21 | 2015-11-25 | 南京正亮医药科技有限公司 | 一种治疗阳痿的中药软膏 |
CN105853867A (zh) * | 2016-05-12 | 2016-08-17 | 广西百琪药业有限公司 | 一种治疗肾阳不足和气血两虚的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN1329056C (zh) | 2007-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20070054222A (ko) | 진통 작용이 있는 약제 조성물 | |
CN105998019A (zh) | 一种治疗脑胶质瘤的药物组合物及其用途 | |
CN102085257B (zh) | 一种桂枝茯苓微丸的制备方法 | |
CN102100735B (zh) | 一种治疗真菌性皮肤病的药物组合物 | |
CN1768820A (zh) | 治疗痛经的药物制剂及其制备方法 | |
CN1772120A (zh) | 一种中药组合物 | |
CN1704113A (zh) | 治疗心脑血管疾病的中药丹红制剂及其制备方法 | |
CN107137485A (zh) | 一种治疗猪瘟的中药注射液及其制备方法 | |
CN1296069C (zh) | 桂枝茯苓组合物及其制备工艺 | |
CN102552377A (zh) | 一种抗辐射损伤药物 | |
CN101991757B (zh) | 一种补肾助阳的中药组合物及其制备方法 | |
CN1762362A (zh) | 一种治疗心脑血管疾病的丹参成份药物组合物及其应用 | |
CN1111412C (zh) | 三七总皂甙软胶囊及其制备工艺 | |
CN1160089C (zh) | 一种治疗高泌乳素血症的颗粒剂的制备方法 | |
CN109394838B (zh) | 一种治疗老年性黄斑变性的药物组合物 | |
CN100337649C (zh) | 治疗类风湿性关节炎的药物及其制备方法 | |
CN1275591C (zh) | 一种治疗心血管疾病的中药缓释剂及其制备方法 | |
CN1895341A (zh) | 一种治疗心脑血管疾病中药制剂 | |
CN110859873A (zh) | 一种小金胶囊及其制备方法 | |
CN105267228B (zh) | 一种药物组合作为制备治疗神经精神障碍性皮肤病药物中的应用 | |
CN1879637B (zh) | 一种治疗心脑血管病的药物 | |
CN1650962A (zh) | 一种用于治疗心律失常的中药制剂及其制备方法 | |
CN103316299B (zh) | 一种治疗原发性肝癌的中药组合物 | |
CN1927288A (zh) | 桂枝茯苓组合物的制备工艺及其用途 | |
CN100349601C (zh) | 一种主治关节炎的中成药及制备和质量控制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HEILONGJIANG TIANYI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHAO YANYI Effective date: 20100928 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100928 Address after: 163316 Jianshe Road high tech Zone, Heilongjiang, No. 245, Patentee after: Heilongjiang Tianyi Pharmaceutical Co., Ltd. Address before: 163316 No. 245, Daqing Development Zone, Daqing, Heilongjiang, Jianshe Road Patentee before: Zhao Yanyi |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine composition Effective date of registration: 20110412 Granted publication date: 20070801 Pledgee: Daqing industrial and commercial Company limited by guarantee Pledgor: Heilongjiang Tianyi Pharmaceutical Co., Ltd. Registration number: 2011990000120 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130820 Granted publication date: 20070801 Pledgee: Daqing industrial and commercial Company limited by guarantee Pledgor: Heilongjiang Tianyi Pharmaceutical Co., Ltd. Registration number: 2011990000120 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: LIU YUJIA Free format text: FORMER OWNER: HEILONGJIANG TIANYI PHARMACEUTICAL CO., LTD. Effective date: 20131029 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 163316 DAQING, HEILONGJIANG PROVINCE TO: 150000 HARBIN, HEILONGJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131029 Address after: 1404 room 150000, building Wang, building 30, Gan Gan Road, Harbin Development Zone, Heilongjiang, China Patentee after: Liu Yujia Address before: 163316 Jianshe Road high tech Zone, Heilongjiang, No. 245, Patentee before: Heilongjiang Tianyi Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20191025 Address after: 150000 cattle industry park, Wuchang City, Heilongjiang, Harbin Patentee after: Harbin Meijun Pharmaceutical Co., Ltd Address before: 1404 room 150000, building Wang, building 30, Gan Gan Road, Harbin Development Zone, Heilongjiang, China Patentee before: Liu Yujia |
|
TR01 | Transfer of patent right |